Inventory

9 Months Ended

Sep. 30, 2020

Inventory Disclosure [Abstract]

Inventory

Inventory

Components of inventory, net of reserves, as of September 30, 2020 and December 31, 2019 are as follows (table in thousands):

	September 30, 2020		December 31, 2019
Raw Materials	$	2,794	$	2,471
Work in Process	329		185
Finished Goods	1,613		1,432
Total	$	4,736	$	4,088

As of September 30, 2020, we classified $0.9 million of inventory as non-current, all of which was related to Triferic or the active pharmaceutical ingredient and raw materials for Triferic. As of September 30, 2020, the total Triferic inventory was $3.8 million, against which we had reserved $2.7 million.

The $1.1 million net value of Triferic inventory consisted of $0.1 million of Triferic Dialysate finished goods with expiration dates ranging from December 2020 to May 2021, $0.3 million of Triferic API with estimated remaining shelf life extending through 2021, and $0.7 million of raw materials for Triferic with estimated remaining shelf life extending beyond 2025.